Blueprint Medicines Corp (BPMC) — Cash Flow Reinvestment Rate
Blueprint Medicines Corp (BPMC) has a Cash Flow Reinvestment Rate of 0.69x as of September 2020, reinvesting $430.14 Million (capex $6.00K plus investments $-430.13 Million) from operating cash flow of $622.33 Million. See how much free cash does Blueprint Medicines Corp generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Blueprint Medicines Corp Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Blueprint Medicines Corp across 1 annual periods. For the full cash flow conversion analysis, see Blueprint Medicines Corp cash flow conversion.
Annual Cash Flow Reinvestment Rate for Blueprint Medicines Corp (2020–2020)
Year-by-year capital reinvestment analysis for Blueprint Medicines Corp. See financial flexibility index of Blueprint Medicines Corp to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.12x | $434.25 Million | $387.04 Million | $3.16 Million | — |